Mutations in TREX1 have been identified in patients with Aicardi-Goutières syndrome (AGS) [27, 28], where accumulated cytoplasmic self-DNAs chronically activate cGAS-mediated type I IFN production, driving systemic inflammation and autoimmune disorders. This evidence concerns the gene TREX1 and autoimmune disease.